FindMyKOL
Clinical trialNCT04362150RecruitingObservational

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

NCT04362150 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies COVID. The registry lists an enrollment of 800 participants at 1 site in 1 country. The registry lists a start date of 21 Apr 2020 and a primary completion date of 31 Dec 2030. One of its registered investigators has a FindMyKOL profile.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04362150
FieldValue
Registry IDNCT04362150
StatusRecruiting
Study typeObservational study
Lead sponsorUniversity of California, San Francisco
Enrollment800
Registered sites1
Countries1
ConditionsCOVID
Start21 Apr 2020
Primary completion31 Dec 2030
Study completion31 Dec 2030
Last update posted23 Jul 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-19, with a focus on understanding variability in the long-term immune response between individuals.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site, 1 recruiting
  • Zuckerberg San Francisco General Hospital (zsfg)

    San Francisco

    Steven G Deeks, MD
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 site, 1 recruitingCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04362150

Each answer restates registry values shown on this page.

What is NCT04362150?

NCT04362150 is an observational study sponsored by University of California, San Francisco. It studies COVID.

Is NCT04362150 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT04362150?

The registry names Michael J Peluso, MD (principal investigator, University of California, San Francisco) and Steven Deeks, MD (principal investigator, University of California, San Francisco) as overall officials.

Where does NCT04362150 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04362150 expected to complete?

The registry lists a primary completion date of 31 Dec 2030 and a study completion date of 31 Dec 2030. The sponsor last updated the record on 23 Jul 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.